1. Home
  2. CLRB vs TKLF Comparison

CLRB vs TKLF Comparison

Compare CLRB & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • TKLF
  • Stock Information
  • Founded
  • CLRB 2002
  • TKLF 2006
  • Country
  • CLRB United States
  • TKLF Japan
  • Employees
  • CLRB N/A
  • TKLF N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • TKLF Other Specialty Stores
  • Sector
  • CLRB Health Care
  • TKLF Consumer Discretionary
  • Exchange
  • CLRB Nasdaq
  • TKLF Nasdaq
  • Market Cap
  • CLRB 17.5M
  • TKLF 15.6M
  • IPO Year
  • CLRB N/A
  • TKLF 2022
  • Fundamental
  • Price
  • CLRB $4.97
  • TKLF N/A
  • Analyst Decision
  • CLRB Hold
  • TKLF
  • Analyst Count
  • CLRB 2
  • TKLF 0
  • Target Price
  • CLRB N/A
  • TKLF N/A
  • AVG Volume (30 Days)
  • CLRB 110.6K
  • TKLF 19.8K
  • Earning Date
  • CLRB 11-17-2025
  • TKLF 07-10-2025
  • Dividend Yield
  • CLRB N/A
  • TKLF N/A
  • EPS Growth
  • CLRB N/A
  • TKLF N/A
  • EPS
  • CLRB N/A
  • TKLF 1.57
  • Revenue
  • CLRB N/A
  • TKLF $210,119,238.00
  • Revenue This Year
  • CLRB N/A
  • TKLF N/A
  • Revenue Next Year
  • CLRB N/A
  • TKLF N/A
  • P/E Ratio
  • CLRB N/A
  • TKLF $2.28
  • Revenue Growth
  • CLRB N/A
  • TKLF 7.38
  • 52 Week Low
  • CLRB $4.11
  • TKLF $2.20
  • 52 Week High
  • CLRB $66.00
  • TKLF $5.80
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 45.44
  • TKLF 47.54
  • Support Level
  • CLRB $4.56
  • TKLF $3.65
  • Resistance Level
  • CLRB $4.98
  • TKLF $3.77
  • Average True Range (ATR)
  • CLRB 0.35
  • TKLF 0.19
  • MACD
  • CLRB -0.13
  • TKLF -0.01
  • Stochastic Oscillator
  • CLRB 18.11
  • TKLF 32.87

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.

Share on Social Networks: